LUS Biomarkers
Cross-source consensus on LUS Biomarkers from 1 sources and 3 claims.
1 sources · 3 claims
How it works
Comparisons
Evidence quality
Highlighted claims
- The interpretable biomarker network estimated 38 LUS biomarkers spanning A-lines, B-lines, pleural abnormalities, consolidations, and effusions. — Prognostic Value of Lung Ultrasound Biomarkers for Readmission Risk in Congestive Heart Failure: A Pilot Data-Driven Analysis
- Pleural Line Location was identified as the most discriminative biomarker by Random Forest feature-selection frequency. — Prognostic Value of Lung Ultrasound Biomarkers for Readmission Risk in Congestive Heart Failure: A Pilot Data-Driven Analysis
- Combining EHR and LUS biomarkers improved held-out test performance compared with either modality alone. — Prognostic Value of Lung Ultrasound Biomarkers for Readmission Risk in Congestive Heart Failure: A Pilot Data-Driven Analysis